High-frequency chest wall compression therapy in neurologically impaired children

Kathryn Fitzgerald1, Jessica Dugre, Sobhan Pagala

  • 1Division of Pediatric Pulmonology, Maimonides Infants and Children's Hospital, Brooklyn, New York.

Respiratory Care
|June 20, 2013
PubMed

Insights

High-frequency chest wall compression (HFCWC) therapy significantly reduced hospitalizations in children with neurological impairments and respiratory issues. This airway clearance technique offers a promising solution for managing respiratory complications in this vulnerable population.

Area of Science:

  • Pediatric Pulmonology
  • Neurology
  • Respiratory Therapy

Background:

  • Neurologically impaired children often experience compromised airway secretion clearance.
  • This can lead to increased respiratory morbidity and frequent hospitalizations.

Purpose of the Study:

  • To evaluate the clinical feasibility and effectiveness of high-frequency chest wall compression (HFCWC) therapy.
  • To assess HFCWC's impact on respiratory symptoms and hospitalizations in neurologically impaired children.

Main Methods:

  • Prospective, single-center study involving 22 subjects over 12 months, with 15 followed for an additional year.
  • Adherence threshold set at 70% for HFCWC therapy.
  • Pulmonary exacerbations requiring hospitalization were the primary outcome measure.

Main Results:

  • Hospital admission rates decreased from 45% pre-HFCWC to 36% after year one and 13% after year two.
  • A statistically significant reduction in hospital days was observed post-treatment.
  • Assisted-cough devices or tracheostomy did not significantly alter hospitalization duration.

Conclusions:

  • Regular high-frequency chest wall compression (HFCWC) therapy demonstrates potential in reducing hospitalizations for neurologically impaired children.
  • HFCWC is a viable option for improving airway clearance and respiratory outcomes in this patient group.
Abstract